Attenuation of Heparan Sulfate Proteoglycan Binding Enhances In Vivo Transduction of Human Primary Hepatocytes with AAV2
Use of the prototypical adeno-associated virus type 2 (AAV2) capsid delivered unexpectedly modest efficacy in an early liver-targeted gene therapy trial for hemophilia B. This result is consistent with subsequent data generated in chimeric mouse-human livers showing that the AAV2 capsid transduces p...
Main Authors: | Marti Cabanes-Creus, Adrian Westhaus, Renina Gale Navarro, Grober Baltazar, Erhua Zhu, Anais K. Amaya, Sophia H.Y. Liao, Suzanne Scott, Erwan Sallard, Kimberley L. Dilworth, Arkadiusz Rybicki, Matthieu Drouyer, Claus V. Hallwirth, Antonette Bennett, Giorgia Santilli, Adrian J. Thrasher, Mavis Agbandje-McKenna, Ian E. Alexander, Leszek Lisowski |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050120300917 |
Similar Items
-
Single amino acid insertion allows functional transduction of murine hepatocytes with human liver tropic AAV capsids
by: Marti Cabanes-Creus, et al.
Published: (2021-06-01) -
Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression
by: Arvindhan Nagarajan, et al.
Published: (2018-08-01) -
Heparan Sulfate Proteoglycans in Human Colorectal Cancer
by: Carolina Meloni Vicente, et al.
Published: (2018-01-01) -
Heparan Sulfate Proteoglycan Signaling in Tumor Microenvironment
by: Valeria De Pasquale, et al.
Published: (2020-09-01) -
Profiling Heparan Sulfate Proteoglycans in Ovarian Carcinoma
by: Andrew R. Clamp, et al.
Published: (2005-01-01)